Adherence of Diuretics in Pulmonary Hypertension

Precapillary Pulmonary Hypertension Clinical Trial

— PHARE  

Official title:

Adherence Assesment for Diuretics in Patients Suffering From Precapillary Pulmonary Hypertension

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05167968
• Other study ID #: 2021-A02137-34
• Status: Recruiting
• Start date: January 13, 2022
• Est. completion date: January 13, 2023

Study information

• Verified date: February 2022
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: Marie-Camille Chaumais, PharmD, PhD
• Phone: 33 (1).45.21.71.72
• Email: mariecamille.chaumais[@]aphp.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In this prospective study, the investigators will implement a systematic assessment of adherence to diuretics in a cohort of patients with precapillary pulmonary hypertension. This study is designed to: - determine the overall adherence rates for diuretic regimen - determine the determinants of non-adherence to diuretics - assess the risk of PH worsening occurrence in the non-adhesion group

Description:

Introduction Precapillary pulmonary hypertension (PH) is characterized by remodeling of small pulmonary arteries leading to a progressive increase in pulmonary vascular resistance (PVR) resulting to right heart failure and ultimately death. The prognosis of PH is closely related to the ability of the right ventricle to adapt to the progressive increase in PVR. The occurrence of acute right ventricular decompensation is associated with a very poor prognosis at short term. The management of precapillary PH is based on specific therapies combined with general measures and supportive therapies. Diuretic treatment is recommended in PAH patients with signs of RV failure and fluid retention (recommendation class I, level of evidence C). The beneficial effect of diuretics is probably essential for preventing episodes of acute right ventricular decompensation. However, no study analyzed the rate of adherence to diuretic regimen in PH patients and the impact of patterns of adherence to diuretics on the outcomes of patients. Aim and objectives The main objectives of this study are to: - determine the overall adherence rates for diuretic regimen - determine the determinants of non-adherence to diuretics - assess the risk of PH worsening occurrence in the non-adherence group Methodology Evaluation of subjects and adhesion to diuretics at inclusion are recorded: - Self-questioning of medication adherence: Girerd questionnaire - Assessment of the Medication Possession Ratio - Social and demographic data - Comorbidities - PH characteristics - Clinical evaluation: dyspnea assessed by NYHA functional class (New York Heart Association Functional Classification : I-IV), signs of right heart failure - Type of treatment regimen - History of serious events including non-programmed hospitalization for PH and/or worsening of the disease (15% reduction in the 6-minute walking test and worsening of the WHO functional class) and/or the need to reinforce specific PH therapies

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 227
• Est. completion date: January 13, 2023
• Est. primary completion date: January 13, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Men and women over 18 years old
• Precapillary PH
• Diuretics treatment for at least 12 months
• Having given his/her non-opposition to participate

Exclusion Criteria:

• Treatment regimen without diuretics
• Diuretics treatment for less than 12 months
• Postcapillary PH
• People refusing or unable to give informed consent
• No affiliation to a regime of social security.
• Protected patients

Related Conditions & MeSH terms

• Hypertension
• Hypertension, Pulmonary
• Precapillary Pulmonary Hypertension

Intervention

Other:
• No intervention (Observational cohort)
For each patient, evaluation and adhesion to diuretics at inclusion are recorded: Self-questioning of medication adherence: Girerd questionnaire Assessment of the Medication Possession Ratio Social and demographic data Comorbidities PH characteristics

Locations

Country	Name	City	State
France	Hospital Bicêtre - Pneumology department	Le Kremlin-Bicêtre

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score of Girerd (French self-administered questionnaire about adherence medication) and level of medication possession ratio (MPR)	Prevalence of high adherence to diuretics in PH patients; Girerd questionnaire is made up of 6 items which are evaluated in a binary way : Yes = 0 point & No = 1 point. Three medication categories are defined : high adherence (score = 6), moderate adherence (score = 4 or 5) and low adherence (score < or = 3). MPR is defined by the ratio between the number of days during which the patient is supplied for his medication and the number of days during he should be supplied his medication, over a given period (12 months). Patients with a MPR > 0,80 are considered to have a high adherence whereas patients with a MPR < 0,80 are considered to have a low adherence to diuretics.	2 weeks previous hospitalization
Secondary	To determine the determinants of non-adherence to diuretics	Determinants related to the patient, treatment, disease and care will be recorded.; Association between selected determinants and adherence to diuretics will be analyzed	12 months previous hospitalization
Secondary	To assess the risk of PH worsening occurrence in the non-adhesion group	Occurrence of serious events including non-programmed hospitalization for PH and/or worsening of the disease (15% reduction in the 6-minute walking test and worsening of the WHO functional class) and/or the need to reinforce specific within the 12 months preceding inclusion.; Comparison of serious event prevalence in the high- and low-adherence groups	12 months previous hospitalization